(NASDAQ: VTYX) Ventyx Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41.92%.
Ventyx Biosciences's earnings in 2025 is -$119,027,000.On average, 10 Wall Street analysts forecast VTYX's earnings for 2025 to be -$121,010,555, with the lowest VTYX earnings forecast at -$139,065,872, and the highest VTYX earnings forecast at -$110,813,437. On average, 10 Wall Street analysts forecast VTYX's earnings for 2026 to be -$137,832,234, with the lowest VTYX earnings forecast at -$163,524,693, and the highest VTYX earnings forecast at -$92,843,690.
In 2027, VTYX is forecast to generate -$134,680,398 in earnings, with the lowest earnings forecast at -$201,261,161 and the highest earnings forecast at -$93,592,430.